Article

Five Dangers Of An Insecure API Supply Chain

By Ken Ball, Commercial Operations Lead, Pfizer CentreOne

iStock-1195574782-chain-link-weak-connection-supply

The diversity and agility of API supply chains are key to ensuring that medicines can be manufactured and delivered to patients on time, even in the face of challenges and unforeseen circumstances.

Ken Ball, Commercial Operations Lead for APIs & Intermediates at Pfizer CentreOne discusses five dangers of an insecure API supply chain.

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

Pfizer CentreOne